Treatment of Implantable NF2 Schwannoma Tumor Models With Oncolytic Herpes Simplex Virus G47Δ

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7701037
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

Anti-Tumor Effect of Oncolytic Herpes Simplex Virus G47delta on Human Nasopharyngeal Carcinoma

Chinese Journal of Cancer
2011English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 With Integrin Β1 Blocking Antibody OS2966

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Tracheal Pseudo-Tumor Caused by Herpes Simplex Virus

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Effect of Γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy